|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 3.310 USD | -8.31% |
|
+5.41% | +7.12% |
| 10-06 | HeartSciences Inc. Receives FDA 510(k) Clearance for its MyoVista wavECG Device | CI |
| 10-06 | Top Premarket Decliners | MT |
Evolution of the Average Target: HeartSciences Inc.
Evolution of the Target Price: HeartSciences Inc.
Changes in Analyst Recommendations: HeartSciences Inc.
9cb874ba7fb384d4.TylGjazfBr0_-UUdOfwrylAiPn7vr9jDGwt1TLMJdwc.HG8hwtboYfwNgBxtcL59vRN2bjC3_ZqkYllAL_BvR0UuYA7U5Ldy6U69DA~9c7aaeac595824eb0726ddb2d1d80f7e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +262.54% | |||
| +7.91% | |||||
| +11.92% | |||||
| +11.72% | |||||
| +22.06% | |||||
| +10.71% | |||||
| +5.84% | |||||
| +4.11% | |||||
| -3.79% | |||||
| +0.68% | |||||
| Average | +33.37% | |||||
| Weighted average by Cap. | +9.06% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.310USD
Average target price
12.00USD
Spread / Average Target
+262.54%
High Price Target
12.00USD
Spread / Highest target
+262.54%
Low Price Target
12.00USD
Spread / Lowest Target
+262.54%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- HSCS Stock
- Consensus HeartSciences Inc.
Select your edition
All financial news and data tailored to specific country editions
